Tag: PhD

Poster-Case Reports / Case Series

Treatment Resistant Tinea Corporis in Multiple Sclerosis Patients Treated with Ocrelizumab

Background: Tinea corporis is a fungal infection of the skin excluding the face, hands, feet, scalp, nail, or groin. It mostly affects the...

Read More

Poster-Complementary and Alternative Therapies

Evaluation of a 6 Week Integrative Medicine Workshop Series on Quality of Life, Self-Efficacy and Wellness in MS

Background: MS care provided in a comprehensive MS center improves outcomes. Well-established MS centers struggle to include complementary...

Read More

Poster-Disease-modifying Therapy

Assessment of Composite Disability Accumulation of Ponesimod Relative to Teriflunomide in the Optimum Phase 3 Study

Background: In relapsing forms of Multiple Sclerosis, disability progression has been shown to be independent of relapses. A new concept in...

Read More

Platform-Disease Management

Prevalence of Cannabis Use and Associated Factors Among People with Multiple Sclerosis: A 2020 NARCOMS Survey

Background: The North American Research Committee on Multiple Sclerosis (NARCOMS) registry is a voluntary, self-report registry for people...

Read More

Platform-Rehabilitation

Spasticity Experience in Adults with Multiple Sclerosis: An Integrated Conceptual Model

Background: Spasticity is a common symptom of multiple sclerosis (MS), often leading to functional limitations and disability. Objectives:...

Read More

Platform-Disease Management

Development and Usability Testing of a Patient-Based Digital Tool to Detect Early Signs of Changes in Multiple Sclerosis Symptoms and Progression: Your MS Questionnaire

Background: The validated physician-completed MSProDiscussTM tool facilitates physician-patient interaction in evaluating early signs of...

Read More

Platform-Disease Modifying Therapies

Efficacy and Safety of Ublituximab Versus Teriflunomide in Relapsing Multiple Sclerosis: Results of the Phase 3 Ultimate I and II Trials

Background: Ublituximab, a novel monoclonal antibody, targets a unique epitope on the CD20 antigen and is glycoengineered for enhanced...

Read More

Platform-Psychosocial

Living with Multiple Sclerosis: Perceptions, Conflicts and Coping

Background: A physical illness causes pain and suffering to not just the person who is diagnosed but also impacts the lives of family...

Read More

Platform-Neuroimaging

A Description of Real-World MRI Acquired in Patients with Multiple Sclerosis: Preliminary Insights from FlywheelMS

Background: Magnetic resonance imaging (MRI) in the context of routine care is an important tool that can inform clinical decisions in...

Read More

Platform-Neuroimaging

Upper Cervical Spinal Cord Myelin Content and Atrophy across the Spectrum of MS Subtypes

Background: The Canadian Prospective Cohort Study to Understand Progression in People Living with MS (CanProCo) aims to better understand...

Read More